Doctors closely monitor myeloma. The tests you have and how often you have them depend on your situation. You might have regular appointments and tests to: monitor myeloma without symptoms ...

There are also some other conditions related to myeloma. For example, MGUS, plasmacytoma and amyloidosis. Some of these conditions can develop into myeloma. To understand about the different types of ...

Electrolyte imbalance is a well–known cause of acute neurological deterioration in the central and peripheral nervous systems. Rapid correction of hyponatraemia1 can cause central pontine myelinolysis ...

BRAF V600E mutations are detected in 3%–10% of patients with multiple myeloma (MM) and are associated with more aggressive disease, higher frequency of extramedullary growth and shorter survival.

Dr K A Miszkiel, Lysholm Department of Radiology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG BACKGROUND Orbital xanthogranuloma, a diagnosis confirmed ...

As opposed to HP-associated gastric MALT lymphomas, the underlying stimulus for lymphoma development cannot be entirely removed in AD patients, as no causative therapy exists for AD. Thus, one could ...

Monoclonal gammopathy subtypes, especially IgM-MG, define distinct clinical subsets in CLL, impacting therapeutic outcomes significantly. IgM-MG is linked to poorer prognostic indicators, including ...

bThe Institute of Cancer Research, The Royal Marsden Hospital NHS Foundation Trust, London, UK Multiple myeloma is the second most common haematological malignancy in high-income countries, and ...

Systemic capillary leak syndrome (SCLS), also known as Clarkson’s disease, is a rare disorder of unknown aetiology. Since SCLS was first described in 1960, fewer than 500 cases have been reported.

This study reports a case of cold agglutinin disease (CAD) secondary to lymphoplasmacytic lymphoma in a patient intolerant to rituximab plus bendamustine and with persistent uncontrolled hemolysis ...

Correspondence to Dr Simon Rinaldi, Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, UK; simon.rinaldi{at}ndcn.ox.ac.uk This review summarises recent evidence ...